Danielle Keatley
Investor Relations Contact presso STRUCTURE THERAPEUTICS INC.
Profilo
Danielle Keatley is currently the Head-Investor Relations at Structure Therapeutics, Inc. Previously, she worked as the Head-Media Relations at Onyx Pharmaceuticals, Inc. from 2012 to 2013.
She also served as the Head-IR & Corporate Communications at Ultragenyx Pharmaceutical, Inc. from 2016 to 2021.
Posizioni attive di Danielle Keatley
| Società | Posizione | Inizio |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Investor Relations Contact | - |
Precedenti posizioni note di Danielle Keatley
| Società | Posizione | Fine |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Investor Relations Contact | 01/08/2021 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Public Communications Contact | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| Aziende private | 1 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Borsa valori
- Insiders
- Danielle Keatley
